Table 4. Logistic Regression Analysis for Association of Progression of PAV and TAV with Clinical Parameters.

	PAV progression		TAV progression
	OR (95% CI)	p-value	OR (95% CI)	p-value
Age	1.01 (0.96–1.06)	0.76	1.00 (0.95–1.06)	0.99
Male gender	1.54 (0.36–6.68)	0.56	4.44 (0.98–20.09)	0.06
DES	1.02 (0.25–4.10)	0.98	1.66 (0.40–6.88)	0.49
Hypertension	0.96 (0.28–3.24)	0.94	0.71 (0.19–2.71)	0.61
Diabetes mellitus	0.93 (0.19–4.43)	0.93	0.59 (0.12–2.89)	0.51
Current smoking at the 1st test	1.39 (0.43–4.49)	0.59	1.61 (0.45–5.76)	0.46
LDL-C at the 1st test	1.00 (0.99–1.02)	0.73	0.99 (0.97–1.01)	0.41
LDL-C at the 2nd test	0.99 (0.97–1.02)	0.64	0.99 (0.97–1.02)	0.55
BNP at the 1st test	0.99 (0.98–1.01)	0.65	1.01 (0.99–1.01)	0.21
BNP at the 2nd test	1.00 (0.99–1.01)	0.99	1.01 (0.99–1.01)	0.10
CRP at the 1st test	0.60 (0.27–1.33)	0.21	0.91 (0.59–1.41)	0.68
CRP at the 2nd test	1.04 (0.74–1.47)	0.38	1.11 (0.79–1.57)	0.54
Responses to ACh
Coronary diameter at the 1st test	1.03 (0.98–1.09)	0.28	0.99 (0.94–1.04)	0.68
Coronary diameter at the 2nd test	0.96 (0.92–1.01)	0.07	0.93 (0.87–0.98)	< 0.01
Coronary flow at the 1st test	1.00 (0.99–1.01)	0.49	1.00 (0.99–1.01)	0.79
Coronary flow at the 2nd test	0.99 (0.98–1.01)	0.28	0.99 (0.98–0.99)	0.02
Responses to SNP
Coronary diameter at the 1st test	1.00 (0.94–1.08)	0.90	0.96 (0.89–1.04)	0.31
Coronary diameter at the 2nd test	1.03 (0.98–1.07)	0.25	0.99 (0.95–1.05)	0.97
Coronary flow at the 1st test	1.00 (0.99–1.01)	0.26	0.99 (0.99–1.01)	0.27
Coronary flow at the 2nd test	1.00 (0.99–1.01)	0.29	0.99 (0.99–1.01)	0.28
Persistent impairment of responses to ACh
Coronary diameter	6.15 (1.35–28.13)	0.02	6.00 (1.36–26.45)	0.02
Coronary flow	4.33 (1.20–15.61)	0.03	5.52 (1.44–21.14)	0.01

OR, odds ratio; CI, confidence interval; other abbreviations as the same as in Tables 1–3.